Source

From U.S. FDA

1 releases originally issued via U.S. FDA. The issuing organizations are responsible for their content.

FDA10h ago

The U.S. Food and Drug Administration today granted accelerated approval for Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd)…